UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Bone marrow transplantation (Basingstoke), 2021-07, Vol.56 (7), p.1651-1664

2021

Volltextzugriff (PDF)

Next generations of CAR-T cells - new therapeutic opportunities in hematology?

Frontiers in immunology, 2022-10, Vol.13, p.1034707-1034707

2022

Volltextzugriff (PDF)

Inflammasomes—New Contributors to Blood Diseases

International journal of molecular sciences, 2022-07, Vol.23 (15), p.8129

2022

Volltextzugriff (PDF)

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

Bone marrow transplantation (Basingstoke), 2019-10, Vol.54 (10), p.1525-1552

2019

Volltextzugriff (PDF)

Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patients

Expert opinion on biological therapy, 2024-05, Vol.24 (5), p.389-397

2024

Volltextzugriff (PDF)

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Bone marrow transplantation (Basingstoke), 2019-10, Vol.54 (10), p.1575-1585

2019

Volltextzugriff (PDF)

Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study

Clinical infectious diseases, 2017-08, Vol.65 (3), p.364-370

2017

Volltextzugriff (PDF)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Bone marrow transplantation (Basingstoke), 2022-08, Vol.57 (8), p.1217-1239

2022

Volltextzugriff (PDF)

Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies

Cancers, 2023-12, Vol.15 (24), p.5765

2023

Volltextzugriff (PDF)

Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

International journal of molecular sciences, 2024-07, Vol.25 (14), p.7743

2024

Volltextzugriff (PDF)

Rapid resolution of COVID-19 after faecal microbiota transplantation

Gut, 2022-01, Vol.71 (1), p.230

2022

Volltextzugriff (PDF)

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1604-1613

2020

Volltextzugriff (PDF)

Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment

International journal of molecular sciences, 2022-11, Vol.23 (23), p.15006

2022

Volltextzugriff (PDF)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

Bone marrow transplantation (Basingstoke), 2020-11, Vol.55 (11), p.2071-2076

2020

Volltextzugriff (PDF)

EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

Bone marrow transplantation (Basingstoke), 2018-11, Vol.53 (11), p.1401-1415

2018

Volltextzugriff (PDF)

How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT

Blood advances, 2020-12, Vol.4 (24), p.6283-6290

2020

Volltextzugriff (PDF)

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

Bone marrow transplantation (Basingstoke), 2018-09, Vol.53 (9), p.1139-1148

2018

Volltextzugriff (PDF)

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.126-136

2020

Volltextzugriff (PDF)

Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma

Frontiers in immunology, 2021-02, Vol.12, p.632937

2021

Volltextzugriff (PDF)

The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma

Frontiers in immunology, 2022-03, Vol.13, p.853540-853540

2022

Volltextzugriff (PDF)

Increased Intestinal Permeability and Stool Zonulin, Calprotectin and Beta-Defensin-2 Concentrations in Allogenic Hematopoietic Cell Transplantation Recipients

International journal of molecular sciences, 2022-12, Vol.23 (24), p.15962

2022

Volltextzugriff (PDF)

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2018-05, Vol.53 (5), p.535-555

2018

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(245)
Mit Volltextzugriff
(259)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(181)
Life Sciences & Biomedicine
(175)
Humans
(114)
Hematology
(90)
Immunology
(80)
Transplantation
(78)
Oncology
(71)
Female
(50)
Male
(49)
Adult
(48)
Stem Cell Transplantation
(45)
Middle Aged
(39)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(36)
Biophysics
(34)
Stem Cells
(33)
Transplants & Implants
(32)
Aged
(31)
Retrospective Studies
(29)
Young Adult
(29)
Hematopoietic Stem Cell Transplantation
(28)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Next generations of CAR-T cells - new therapeutic opportunities in hematology?

Inflammasomes—New Contributors to Blood Diseases

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

Meta-analysis of response rates to first-line salvage treatment after CAR-T therapy failure in large B-cell lymphoma patients

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies

Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies

Rapid resolution of COVID-19 after faecal microbiota transplantation

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus

Modern Advances in CARs Therapy and Creating a New Approach to Future Treatment

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy

EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

Perspectives for the Use of CAR-T Cells for the Treatment of Multiple Myeloma

Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma

Increased Intestinal Permeability and Stool Zonulin, Calprotectin and Beta-Defensin-2 Concentrations in Allogenic Hematopoietic Cell Transplantation Recipients

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

Suchergebnisse filtern